Company Filing History:
2 out of 2,893 
2 out of 15,475 
Years Active: 2019-2021
Title: **The Innovations of Kevin D. Rynearson: A Pioneer in Alzheimer’s Disease Research**
Introduction
Kevin D. Rynearson, based in La Mesa, California, is an accomplished inventor known for his significant contributions to the field of Alzheimer's disease research. With a total of two patents to his name, his work focuses on developing potent gamma-secretase modulators that aim to provide new therapeutic avenues for disorders associated with aberrant amyloid-beta peptide levels.
Latest Patents
Rynearson's latest innovations include two prominent patents that are crucial in the fight against Alzheimer's disease. The first patent deals with compounds and methods specifically designed for treating conditions related to abnormal amyloid-beta peptide levels, highlighting a direct connection to Alzheimer's disease. The second patent similarly addresses this pressing issue, offering additional formulations and methods to combat the disorder. These patents involve compositions and methods utilizing specific structural formulas, which may include various compounds that show promise in therapeutics.
Career Highlights
Throughout his career, Kevin D. Rynearson has collaborated with notable institutions such as The General Hospital Corporation and the University of California. His experience in these prestigious organizations allows him to blend academic research with practical applications in the pharmaceutical field.
Collaborations
Rynearson has had the opportunity to work alongside esteemed colleagues, including Steven L. Wagner and William C. Mobley. Their collaborative efforts have undoubtedly contributed to the advancement of research and the development of innovative solutions to complex health challenges.
Conclusion
Kevin D. Rynearson's inventions are pivotal in addressing critical health issues like Alzheimer's disease. As a skilled inventor, he continues to pave the way for innovative treatments through his patents and collaborative work, showcasing the importance of dedicated research in the pharmaceutical realm.